What’s New at Faber

Faber’s dynamic and diverse team of lawyers, contracts specialists, and other supporting professionals is committed to client service and the greater community. We are thought leaders and innovative counselors in the fields of life science and high tech.

Faber Co-Sponsors a Year of Free LabShares Office and Lab Space for Life Science Start-Up

April 2019

Affordable workspace can be difficult for biotechnology and life science startups to secure. But thanks to a generous co-sponsorship by Faber Daefuer & Itrato, one emerging company will receive a year’s worth of free access to an innovative workspace.

LabShares Newton has developed a state-of-the-art facility that is fully permitted and professionally maintained, offering a variety of support services and amenities to early-stage research companies at an affordable cost. Initially launching in October 2018, the coveted LabShares space opened at near capacity. In an effort to provide even greater assistance, they recently expanded the facility to accommodate up to 30 companies.

Read Full Story
Faber Announces its Fourth Annual Partnership with deCordova Sculpture Park and Museum

March 2019

Faber Daeufer & Itrato announces its fourth consecutive year as a Corporate Patron in partnership with the deCordova Sculpture Park and Museum. Located in Lincoln, Massachusetts, the museum showcases the work of contemporary New England-based artists. With over 3,400 works in its collection and more than 60 sculptures in its 30-acre park, the museum provides a beautiful showcase for contemporary New England art.

Read Full Story
Greg Ikonen Speaks at 2018 LES Annual Conference on How Emerging Biotech Companies Can Successfully Negotiate Complex Technology License Deals with Big Pharma

February 2019

Faber Daeufer & Itrato principal Greg Ikonen recently shared his expertise as a speaker at the 2018 Licensing Executives Society (LES) conference, discussing the diverse perspectives that parties bring to technology license deals. “I was one of three speakers with substantial experience doing deals in the real world between larger and smaller partners,” Greg explained. “We talked about negotiation goals and strategies from the perspective of big, medium, and small parties, and shared some useful war stories.”

Read Full Story
Faber (Again) Represents Many of the Annual "Fierce 15"

December 2018

FierceBiotech recently released its annual “Fierce 15” list, and four of the innovative winners have relied upon Faber lawyers and contract specialists for their transactional representation needs.

The “Fierce 15” list seeks to recognize the “biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven't been done before.” From a significant group of contenders, FierceBiotech narrows down the list to “15 privately held drug developers or platform biotechs with the potential to have a huge impact on the treatment of human diseases.” It is a celebration of the fierceness, innovation and creativity that makes these biotech companies stand out within a field of fierce competition.

Read Full Story
Faber Works with Gaining Ground to Support Local Hunger Relief

October 2018

Faber staff members recently got their hands dirty when they donated their time and efforts to helping feed individuals in need throughout Greater Boston and Eastern Massachusetts. Gaining Ground is an organization that grows organic produce and distributes it for hunger relief. With help from volunteers of all ages and abilities, Gaining Ground’s produce goes straight from the farm to homeless shelters, food pantries, and various local meal programs.

Read Full Story
Successful Faber Seminar Provides Valuable Insight on Clinical Trial Challenges

August 2018

Clinical trial professionals and in-house counsel from many emerging drug development companies in the Bay Area received valuable advice when they attended a seminar on “Optimizing Clinical Trial Agreements for Effective Trial Management” on May 9, 2018, sponsored by Faber Daeufer & Itrato PC and hosted by the California Life Sciences Association (CLSA). The half-day event in South San Francisco, designed to assist biotech professionals efficiently manage the clinical trial process and avoid common challenges, provided a rare opportunity for skilled advice and counsel, as well as highly useful peer involvement and information sharing.

Read Full Story
Faber Welcomes Two New Associates Amidst Domestic and Global Expansion

July 2018

Furthering efforts to expand its clinical trial agreement capabilities, Faber Daeufer & Itrato PC welcomed the addition of two new team members, each with extensive domestic and global clinical trial experience. Nirosha Sithirapathy and M. (Max) Masaya Seltzer recently joined the talented group of Faber lawyers, bringing highly skilled industry-side knowledge to the firm’s pharma, life science and emerging technologies clients.

“The firm is hiring and training more lawyers and contract specialists to support our clients’ clinical trial contracting needs for large, complex, multi-center, global clinical studies,” explained firm principal Sumy Daeufer. “Both Max and Nirosha have in-house legal experience directly relevant to clinical trial contracting. Max brings many years of experience handling clinical trial and other human research related contracts for the NYU School of Medicine, one of the premier institutions in the United States. Nirosha, who is based in the UK, brings European clinical contracting experience from her work with several contract research organizations.”

Read Full Story
Faber-Sponsored Basketball Tournament Wins Big for Special Olympics

June 2018

Faber joined with  many clients and friends in the Boston-area biotech community to score big  with the 2018 Bio-Ball tournament, the wildly-popular annual fundraiser for  Special Olympics Massachusetts, raising a record $360,000. Approximately 650  athletes and spectators turned out for the event, which took place at the  Cambridge Rindge and Latin School on March 24. For more than a decade, Faber has  been the lead sponsor for the event, providing in aggregate over $150,000 in  financial support, and also has regularly fielded its own team of committed  volunteers to help organizers from Special Olympics Massachusetts ensure the  event runs smoothly.

The “CEO Free Throw  Contest” opened a day of enthusiastic, good-natured rivalry, as executives  from each of the 16 participating biotech companies teamed with a Special  Olympics athlete to show off their shooting skills. A red “Unified Ball,”  symbolizing social inclusion, was thrown by the Special Olympians, as the  crowd went wild.

Read Full Story
Faber Staff and Families Participate in Wine To Water Filter Build

April 2018

Faber staff members are consistently looking for worthy causes that need hands-on volunteers to achieve their philanthropic goals. So, when Patricia Wolfe saw a feature story on the not-for-profit organization Wine To Water, she wasted no time bringing the new service idea to the firm.

“My husband and I were having dinner at a restaurant and there was a video on the television monitor about Wine To Water and how they were constructing clean water systems in South America out of clay,” explained Wolfe. “I couldn’t really hear the report, but I looked into the organization later. At Faber, we try to do two or three days of philanthropic service each year. I found out that Wine To Water provides tiny, portable water filters to people in need and they look for companies to sponsor their builds.”

Read Full Story
The Right Experience Can Level the Playing Field

The WAVE/Pfizer Collaboration

February 2018

The Background
In 2015, WAVE Life Sciences was a small biotech company seeking its first big research and development collaboration deal. It had developed a novel technology platform for the discovery and development of new oligonucleotide therapeutics for a wide range of diseases, and was advancing lead candidates in several of its key therapeutic areas. WAVE had identified a promising collaboration opportunity: a multi-program, option-based drug discovery, development and commercialization deal with Pfizer. This deal would combine WAVE’s proprietary oligonucleotide platform with Pfizer’s liver targeting technology, and leverage Pfizer’s drug development and marketing expertise. Pfizer would provide R&D funding, and would have options to acquire exclusive worldwide license rights to therapeutics for several liver-related disorders.

Read Full Story
Working to protect our clients’ confidential information through Transport Layer Security (TLS)

October 2017

We get it. Our clients’ days are filled with pharmacokinetic testing, enrolling global clinical trials and pursuing financing and strategic transactions. Email encryption and Transport Layer Security (TLS) probably don’t rank at the top of their agendas. Faber Daeufer & Itrato’s team of lawyers and contracts specialists are well-known for providing our clients an extraordinary approach to counseling on all of the contracts and transactions that support scientific development and propel growth. But more recently, as we’ve made substantial investments in improving our own cybersecurity, we’ve become proactive in helping our clients address cybersecurity threats when we recognize that their security measures should be improved.

Read Full Story
Faber Attorney Leads BIO Contracts Course

Focus Is on Real World Dynamics

July 2017

Mark J. Cooper, Of Counsel with Faber Daeufer & Itrato, recently co-taught the “Contract Basics” segment of BIO’s Business Development Fundamentals course, held during the trade association’s June 17-19 conference in San Diego.  He collaborated with Pauline Jen Ryan, of Red Sky Partners, on the four-hour workshop, which offered real world perspectives on how to structure and negotiate life science business deals.

Read Full Story
Mark Cooper Joins Faber

Extraordinary Team of Seasoned In-House Lawyers Targets Complex Pharma Collaborations

May 2017

Mark J. Cooper has joined Faber’s New York office, further expanding the firm’s extraordinary team of senior lawyers focused on complex licensing and collaboration agreements for the life sciences.  He recently served as Vice President and Assistant General Counsel for Pfizer’s Business Transactions Group.

Read Full Story
Faber Opens San Francisco Bay Area Office

April 2017

This past fall, Faber launched a major initiative to build capability in the San Francisco market, opening a new office and hiring senior talent. “Given the firm’s focus on the life sciences industry, a lot of our clients are located in California, and we see significant growth opportunities,” explains Greg Ikonen, who recently joined the firm and is leading its Bay Area office.

Read Full Story
Faber Principal Points to the Unique Traits of Gene Therapy Deals

February 2017

In fall 2016, Robert A. Aboud, a principal with Faber who leads the Philadelphia office, spoke about the unique traits and challenges of gene therapy and cell-based therapy deals at CBI’s Life Sciences Summit on M&A and Strategic Alliances in Cambridge, Massachusetts.

Read Full Story
New Faber Staff Deepen Focus

February 2017

During 2016, Faber further strengthened its professional lineup in key disciplines...

Read Full Story
Philadelphia Office Expands

January 2017

Faber recently opened new offices in the Philadelphia mainline suburbs in Radnor, Pennsylvania, an area that is home to many world class pharmaceutical and biotech companies, and is a hotbed of biotech innovation for the region.

Read Full Story
Faber a Legal Industry Leader in Cloud Computing

November 2015

Faber has been a geographically dispersed firm since inception, taking advantage of cloud technologies such as secure online backup.

Read Full Story
Serving Our Communities

November 2015

On September 27, 2015, Faber held its first annual firm-wide Day of Service, partnering with the Boston Cares Bed Project.

Read Full Story
Faber Becomes First Law Firm to Gain “Road Warrior” Certification

November 2015

Working from anywhere in the world and under any conditions are two critical factors in providing great service to a global client base. 

Read Full Story
Faber Grows Again

November 2015

Faber is expanding once again to accommodate growth. Starting with six employees about twelve years ago, the firm has grown to over 30.

Read Full Story